Corrigendum to “Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice”
Main Authors: | Xiao-Wen Chen, Xiao-Yan Du, Yu-Xian Wang, Jian-Cheng Wang, Wen-Ting Liu, Wen-Jing Chen, Hong-Yu Li, Fen-Fen Peng, Zhao-Zhong Xu, Hong-Xin Niu, Hai-Bo Long |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2016/3151986 |
Similar Items
-
Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice
by: Xiao-Wen Chen, et al.
Published: (2016-01-01) -
Mycophenolate Mofetil Ameliorates Diabetic Nephropathy in db/db Mice
by: Jung-Woo Seo, et al.
Published: (2015-01-01) -
Anti-Diabetic Nephropathy Activities of Polysaccharides Obtained from <i>Termitornyces albuminosus</i> via Regulation of NF-κB Signaling in db/db Mice
by: Chang Yang, et al.
Published: (2019-10-01) -
Dietary Leucine Supplement Ameliorates Hepatic Steatosis and Diabetic Nephropathy in db/db Mice
by: Kuan-Hsing Chen, et al.
Published: (2018-06-01) -
Therapeutic potential of NaoXinTong Capsule on the developed diabetic nephropathy in db/db mice
by: Shu Yang, et al.
Published: (2019-10-01)